News | Scientists Identify Genetic Links Between Menopause and Cancer Risk
A recent Nature study identified rare genetic mutations that affect the timing of menopause and increase cancer risk, offering new insight into the genetic factors behind female reproductive health and lifespan.
Researchers analyzed whole-exome sequencing data from more than 100,000 postmenopausal women in the UK Biobank and identified nine rare variants associated with age at menopause. These mutations may advance menopause by as much as 5.61 years and significantly affect reproductive lifespan and health risks.
How Do Rare Mutations Affect Menopause and Cancer Risk?
A woman's ovarian reserve is established before birth and gradually declines throughout her reproductive years, eventually leading to menopause. Natural fertility generally begins declining 10 years before menopause. Timing depends on the initial oocyte pool and the rate of follicle loss.
The study identified several mutations associated with age at natural menopause (ANM), including DNA damage-repair genes such as BRCA2 and CHEK2, which are closely linked to cancer risk. These rare variants affected menopause timing and were associated with higher risks of hormone-sensitive cancers, including breast and prostate cancer.
New Genetic Findings and Reproductive Health
A key finding was a ZNF518A mutation significantly associated with menopause occurring 5.61 years earlier. These genes were also linked to delayed puberty, further supporting ZNF518A's role in regulating female reproductive lifespan. Rare variants had a greater effect on menopause timing than common variants.
Future Research: Early Ovarian Aging and Mutation Rates in Offspring
The study also examined whether genetic susceptibility to early ovarian aging increases de novo mutations in offspring. An association in the initial analysis was not confirmed in an independent cohort, prompting calls for larger studies.
Conclusion
Overall, the study identified nine genes related to ovarian aging and further linked them to cancer risk. The findings may inform new approaches to extending reproductive lifespan and reducing cancer risk, while highlighting the need to study the long-term effects of genetic variation on women's health.
News | Scientists Identify Genetic Links Between Menopause and Cancer Risk
News | Scientists Identify Genetic Links Between Menopause and Cancer Risk
A recent Nature study identified rare genetic mutations that affect the timing of menopause and increase cancer risk, offering new insight into the genetic factors behind female reproductive health and lifespan.
Researchers analyzed whole-exome sequencing data from more than 100,000 postmenopausal women in the UK Biobank and identified nine rare variants associated with age at menopause. These mutations may advance menopause by as much as 5.61 years and significantly affect reproductive lifespan and health risks.
How Do Rare Mutations Affect Menopause and Cancer Risk?
A woman's ovarian reserve is established before birth and gradually declines throughout her reproductive years, eventually leading to menopause. Natural fertility generally begins declining 10 years before menopause. Timing depends on the initial oocyte pool and the rate of follicle loss.
The study identified several mutations associated with age at natural menopause (ANM), including DNA damage-repair genes such as BRCA2 and CHEK2, which are closely linked to cancer risk. These rare variants affected menopause timing and were associated with higher risks of hormone-sensitive cancers, including breast and prostate cancer.
New Genetic Findings and Reproductive Health
A key finding was a ZNF518A mutation significantly associated with menopause occurring 5.61 years earlier. These genes were also linked to delayed puberty, further supporting ZNF518A's role in regulating female reproductive lifespan. Rare variants had a greater effect on menopause timing than common variants.
Future Research: Early Ovarian Aging and Mutation Rates in Offspring
The study also examined whether genetic susceptibility to early ovarian aging increases de novo mutations in offspring. An association in the initial analysis was not confirmed in an independent cohort, prompting calls for larger studies.
Conclusion
Overall, the study identified nine genes related to ovarian aging and further linked them to cancer risk. The findings may inform new approaches to extending reproductive lifespan and reducing cancer risk, while highlighting the need to study the long-term effects of genetic variation on women's health.
Story source:
Collected online